Eric T. Wong, MD, Associate Professor at Harvard Medical School discusses some of the reasons that a patient will be interested in participating in a clinical trial, especially one involving a rare disease.

Some of the reasons include:

  • No treatment is currently available
  • Current treatment is not effective
  • Current treatment has intolerable side effects
  • A desire to advance our understanding of a disease
  • Gain access to newer treatments

To learn more about rare disease clinical trials, and receive continuing medical education credit, go to


  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.